Anti-CD85 / ILT2 / ILR1 antibody

Anti-CD85 / ILT2 / ILR1 antibody

• Material Safety Data Sheets (MSDS)

Mouse monoclonal to CD85 / ILT2 / ILR1

FCM

Human CD85 / ILT2 / ILR1

leukocyte immunoglobulin-like receptor antibody; subfamily B (with TM and ITIM domains) antibody; member 1 antibody; LILRB1 antibody; XXbac-BCX85G21.4 antibody; CD85 antibody; CD85J antibody; ILT-2 antibody; ILT2 antibody; LIR-1 antibody; LIR1 antibody; MIR-7 antibody; MIR7 antibody; CD85 antigen-like family member J antibody; Ig-like transcript 2 antibody; immunoglobulin-like transcript 2 antibody; leukocyte Ig-like receptor-1 antibody; leukocyte immunoglobulin-like receptor subfamily B member 1 antibody; leukocyte immunoglobulin-like receptor subfamily B member 1 soluble isoform antibody; monocyte/macrophage immunoglobulin-like receptor 7 antibody

Mouse IgG1

This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD85 / ILT2 / ILR1 (rh CD85 / ILT2 / ILR1; Q4QQW2_RAT; Met1-His458) and conjugated with PE under optimum conditions, the unreacted PE was removed.

Monoclonal

Aqueous solution containing 0.5% BSA and 0.09% sodium azide

This antibody is stable for 12 months from date of receipt when stored at 2℃-8℃. Protected from prolonged exposure to light. Do not freeze !
Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.

FCM